Biomerica Inc.

4.56-0.0500-1.08%Vol 11.52K1Y Perf -30.85%
Sep 23rd, 2021 13:43 DELAYED
BID4.52 ASK4.60
Open4.66 Previous Close4.61
Pre-Market- After-Market-
 - -%  - -
Target Price
11.25 
Analyst Rating
Strong Buy 1.00
Potential %
147.25 
Finscreener Ranking
★★★★+     55.63
Insiders Trans % 3/6/12 mo.
-/-/100 
Value Ranking
★★     47.12
Insiders Value % 3/6/12 mo.
-/-/100 
Growth Ranking
★★★+     54.53
Insiders Shares Cnt. % 3/6/12 mo.
-/-/100 
Income Ranking
 —    -
Price Range Ratio 52W %
25.98 
Earnings Rating
Neutral
Market Cap57.05M 
Earnings Date
21st Oct 2021
Alpha0.04 Standard Deviation0.26
Beta-0.68 

Today's Price Range

4.554.66

52W Range

3.308.15

5 Year PE Ratio Range

-20.90-16.90

Summary:

Buy

Technical Indicators: Neutral
Moving Averages: Strong Buy
Performance
1 Week
9.76%
1 Month
8.73%
3 Months
11.35%
6 Months
-27.52%
1 Year
-30.85%
3 Years
31.71%
5 Years
67.03%
10 Years
924.44%

TickerPriceChg.Chg.%
BMRA4.56-0.0500-1.08
AAPL146.911.06000.73
GOOG2 841.8923.12000.82
MSFT300.101.52000.51
XOM57.071.86003.37
WFC48.060.98002.08
JNJ165.551.62000.99
FB346.803.59001.05
GE103.785.24005.32
JPM161.555.64003.62
Financial StrengthValueIndustryS&P 500US Markets
4.30
7.10
0.12
0.18
-17 590.20
Leverage Ratio 1.30
ProfitabilityValueIndustryS&P 500US Markets
6.90
-89.70
-84.50
-49.30
-79.59
RevenueValueIndustryS&P 500US Markets
6.06M
0.48
11.84
5.68
Earnings HistoryEstimateReportedSurprise %
Q04 2021-0.10-0.12-20.00
Q03 2021-0.02-0.15-650.00
Q02 2021-0.10-0.13-30.00
Q01 2021-0.09-0.14-55.56
Q04 2020-0.06-0.0433.33
Q03 2020-0.07-0.09-28.57
Q02 2020-0.08-0.0537.50
Q01 2020-0.06-0.0516.67
Earnings Per EndEstimateRevision %Trend
5/2021 QR-0.03-200.00Negative
8/2021 QR-0.12-160.00Negative
5/2022 FY-0.49-206.25Negative
5/2022 FY0.2945.00Positive
Next Report Date21st Oct 2021
Estimated EPS Next Report-0.12
Estimates Count1
EPS Growth Next 5 Years %25.00
Volume Overview
Volume11.52K
Shares Outstanding12.51M
Shares Float10.38M
Trades Count72
Dollar Volume338.59K
Avg. Volume279.17K
Avg. Weekly Volume48.18K
Avg. Monthly Volume54.26K
Avg. Quarterly Volume120.00K

Biomerica Inc. (NASDAQ: BMRA) stock closed at 4.61 per share at the end of the most recent trading day (a 2.67% change compared to the prior day closing price) with a volume of 40.76K shares and market capitalization of 57.05M. Is a component of indices and it is traded on NASDAQ exchange. The company belongs in the Medical Diagnostics & Research industry, Healthcare sector and employs 45 people. Biomerica Inc. CEO is Zackary S. Irani.

The one-year performance of Biomerica Inc. stock is -30.85%, while year-to-date (YTD) performance is -7.43%. BMRA stock has a five-year performance of 67.03%. Its 52-week range is between 3.3 and 8.15, which gives BMRA stock a 52-week price range ratio of 25.98%

Biomerica Inc. currently has a PE ratio of -8.60, a price-to-book (PB) ratio of 6.30, a price-to-sale (PS) ratio of 9.05, a price to cashflow ratio of 99.50, a PEG ratio of 2.32, a ROA of -44.49%, a ROC of -48.55% and a ROE of -55.26%. The company’s profit margin is -79.59%, its EBITDA margin is -84.50%, and its revenue ttm is $6.06 Million , which makes it $0.48 revenue per share.

Of the last four earnings reports from Biomerica Inc., there were 0 positive earnings surprise and 4 negative earnings surprise. The company has EPS estimate of $-0.12 for the next earnings report. Biomerica Inc.’s next earnings report date is 21st Oct 2021.

The consensus rating of Wall Street analysts for Biomerica Inc. is Strong Buy (1), with a target price of $11.25, which is +147.25% compared to the current price. The earnings rating for Biomerica Inc. stock is Neutral (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

Biomerica Inc. has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.

Biomerica Inc. has a Buy technical analysis rating based on Technical Indicators (ADX : 21.70, ATR14 : 0.27, CCI20 : 58.37, Chaikin Money Flow : 0.14, MACD : 0.10, Money Flow Index : 58.62, ROC : -2.33, RSI : 57.71, STOCH (14,3) : 75.68, STOCH RSI : 0.84, UO : 48.24, Williams %R : -24.32), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of Biomerica Inc. in the last 12-months were: Catherine Coste (Buy at a value of $49 595)

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
1 (100.00 %)
1 (100.00 %)
1 (100.00 %)
Moderate Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Hold
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Summary RatingStrong Buy
1.00
Strong Buy
1.00
Strong Buy
1.00

Biomerica Inc.

Biomerica Inc is engaged in the development, manufacturing, and marketing medical diagnostic products designed for the early detection and monitoring of chronic diseases and medical conditions. The company focuses on products for gastrointestinal diseases, food intolerances, diabetes, and certain esoteric tests. It operates in one segment namely, the design, development, marketing and sales of diagnostic kits. Majority of the company's revenue is earned from the Europe market.

CEO: Zackary S. Irani

Telephone: +1 949 645-2111

Address: 17571 Von Karman Avenue, Irvine 92614, CA, US

Number of employees: 45

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

92%8%

Bearish Bullish

55%45%

Bearish Bullish

61%39%

TipRanks News for BMRA

Mon, 30 Aug 2021 11:45 GMT Biomerica (BMRA) Receives a Buy from Colliers Securities

- TipRanks. All rights reserved.

News

Stocktwits